Vident Investment Advisory’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,198
Closed -$145K 615
2023
Q2
$145K Sell
10,198
-3,665
-26% -$51.5K 0.01% 1100
2023
Q1
$207K Buy
13,863
+3,851
+38% +$58.3K 0.01% 1095
2022
Q4
$149K Buy
+10,012
New +$163K 0.01% 1066
2022
Q3
Sell
-21,202
Closed -$440K 1232
2022
Q2
$440K Buy
21,202
+3,042
+17% +$62.1K 0.01% 896
2022
Q1
$425K Sell
18,160
-45,693
-72% -$1.12M 0.01% 982
2021
Q4
$1.74M Buy
63,853
+2,509
+4% +$67.2K 0.05% 507
2021
Q3
$1.74M Sell
61,344
-1,294
-2% -$39.4K 0.05% 495
2021
Q2
$1.89M Sell
62,638
-1,917
-3% -$56.6K 0.06% 430
2021
Q1
$1.64M Sell
64,555
-727
-1% -$18.6K 0.06% 465
2020
Q4
$1.6M Sell
65,282
-3,808
-6% -$71.5K 0.07% 373
2020
Q3
$1.13M Sell
69,090
-6,205
-8% -$115K 0.06% 458
2020
Q2
$1.29M Sell
75,295
-12,122
-14% -$180K 0.07% 389
2020
Q1
$1.02M Buy
87,417
+41,750
+91% +$861K 0.07% 392
2019
Q4
$1.27M Buy
+45,667
New +$1.15M 0.08% 368
2015
Q3
Sell
-7,653
Closed -$567K 1104
2015
Q2
$567K Buy
7,653
+280
+4% +$20.2K 0.08% 421
2015
Q1
$535K Buy
+7,373
New +$513K 0.11% 369

Other funds holding MD

Vident Investment Advisory's MD Position: Q3 2023 in Review

Vident Investment Advisory sold out of Pediatrix Medical (MD) in Q3 2023, closing a stake of 10,198 shares — an estimated $145K sold.

Vident Investment Advisory first reported a position in MD in Q1 2015 and held it in 16 quarters. The position peaked at $1.89M in Q2 2021. 205 funds tracked by Wall St. Rank hold MD as of Q3 2023.

  • Vident Investment Advisory reported no remaining Pediatrix Medical position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 10,198 Pediatrix Medical shares in Q3 2023, an estimated $145K.
  • Vident Investment Advisory first reported a position in Pediatrix Medical in Q1 2015 and held it in 16 quarters.
  • Vident Investment Advisory's Pediatrix Medical position peaked at $1.89M in Q2 2021.
  • 205 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.